In this study calendering is used as a downstream technique to shape monolithic co-extruded fixed-dose combination products in a continuous way. Co-extrudates with a metoprolol tartrateloaded sustained-release core and a hydrochlorothiazide-loaded immediate-release coat were produced and immediately shaped into a monolithic drug delivery system via calendering, using chilled rolls with tablet-shaped cavities. In vitro metoprolol tartrate release from the ethylcellulose core of the calendered tablets was prolonged in comparison to the sustained release of a multiparticulate dosage form, prepared manually by cutting co-extrudates into mini-matrices. Analysis of the dosage forms using X-ray micro-computed tomography only detected small differences between the pore structure of the core of the calendered tablet and the mini-matrices. Diffusion path length was shown to be the main mechanism behind the release kinetics. Terahertz pulsed imaging visualized that adhesion between the core and coat of the calendered tablet was not complete and a gradient in coat thickness (varying from 200 to 600 µm) was observed. Modulated differential scanning calorimetry and X-ray diffraction indicated that the solid state properties of both drugs were not affected by the calendering procedure.
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INTRODUCTION
In co-extrusion two or more formulations are simultaneously processed via hot-melt 1 a monolithic FDC dosage form was evaluated. In the treatment of cardiovascular disease the 27 FDC of the beta-blocker metoprolol tartrate (MPT) with the diuretic hydrochlorothiazide (HCT) 28 is well established [13] . Therefore co-extrudates consisting of a plasticized ethylcellulose (EC) 29 core, containing MPT and polyethylene oxide (PEO), and a coat of polyethylene oxide (PEO) 30 / polyethylene glycol (PEG) containing HCT were previously developed [14] . After production 31 the cylindrical co-extrudate with concentric coat layer was immediately shaped via calendering, 32 using chilled rolls with tablet-shaped cavities. In this way monolithic dosage forms with a 33 sustained-release core, loaded with MPT as model drug, and an immediate-release coat, 34
loaded with HCT as model drug, were produced and evaluated for in vitro drug release, coat 35 thickness and uniformity and pore structure. The impact of the calendering step on the physical 36 state of the drugs in the formulations was characterized using modulated differential scanning 37 calorimetry (MDSC) and X-ray diffraction (XRD). 38
Materials 40
Metoprolol tartrate (MPT) ( Colorcon, Dartford Kent, United Kingdom) and polyethylene glycol (PEG) 4K (MW: 4000 g/mol, 47
Fagron, Waregem, Belgium) were used. All other chemicals were of analytical grade. 48
Methods 49
Co-extrusion 50
Co-extrusion was carried out using two co-rotating Prism Eurolab 16 mm twin-screw 51 extruders (ThermoFisher Scientific, Karlsruhe, Germany), connected to a co-extrusion die 52 (Guill, West Warwick, USA). In the calendering set-up the co-extrusion die was adapted to fit 53 the diameter of the co-extrudate with the dimensions of the calender cavities, shaping a 54 cylindrical co-extrudate consisting of a core with a diameter of 4 mm and a concentric coat with 55 a thickness of 2 mm. To produce the multiparticulates, a cylindrical co-extrudate with an inner 56 diameter of 3 mm and an outer diameter of 4 mm was manufactured. The heating zones of 57 both extruders were heated to 80/90/100/100/100/100 °C from feed opening to die-end. The 58 co-extrusion die was heated to 100 °C. Both premixes were fed separately into an extruder by 59 a Brabender Flexwall ® loss-in-weight powder feeder (Brabender, Duisburg, Germany) at a feed 60 rate of 200 g/h for the coat and 300 g/h for the core material. A screw speed of 40 rpm and 61 150 rpm was used for the extruder producing the outer layer and the inner layer, respectively. 62
Downstream processing 63
Calendering was performed with a Collin 60 mm calender (Dr. Collin, Ebersberg,speed of the calender rolls was set at 1.5 rpm. Immediately after leaving the co-extrusion die 67 the co-extruded strand was guided between a pair of chilled pressurized rolls that contained 68 tablet-shaped cavities, yielding tablets with a diameter of 8 mm and a thickness of 5 mm. 69
To test the effect of cooling on the MPT release a core extrudate was prepared using the 70 same process parameters as for the core in the co-extrudate. Part of this material was cooled 71 at room temperature, while the remaining part was quench-cooled by dipping the core 72 extrudate in liquid nitrogen immediately after extrusion. 73
Multiparticulates were obtained by manually cutting a cylindrical co-extrudate with an inner 74 diameter of 3 mm and an outer diameter of 4 mm into mini-matrices of 2 mm length after 75 cooling the co-extruded rod to room temperature. 76
In vitro drug release 77
In vitro dissolution was performed using United States Pharmacopeia (USP) dissolution 78 apparatus 1 (baskets) on an Evolution 6300 dissolution system (Distek, New Brunswick, New 79 Jersey, USA), coupled with an Evolution 4300 automatic dissolution sampler (Distek, New 80
Brunswick, New Jersey, USA). The temperature of the dissolution medium (900 ml) was kept 81 at 37 ± 0.5 °C and the rotational speed of the baskets was set to 100 rpm. For the first hour a 82 0.1 N solution of hydrochloric acid (pH 1) was used as the dissolution medium. Afterwards the 83 baskets containing the mini-matrices or tablets were transferred to vessels filled with 84 phosphate buffer pH 6.8 (USP) as the dissolution medium. Samples (filtered using Distek 45 85 µm filters) of 5 ml were withdrawn at 5, 10, 15, 20, 30, 45 and 60 minutes for the determination 86 of HCT concentration in the first dissolution medium and at 1, 2, 4, 6, 8, 12, 16, 20 and 24 87 hours for the determination of MPT concentration in the second dissolution medium. The core 88 layer was analyzed separately to cover for the MPT release during the first hour. Samples were 89 analyzed spectrophotometrically at 316.6 and 222.0 nm, using a UV-spectrophotometer, type 90
The solubility of HCT in the coat of the tablet was studied by cyclic heating of an 94 oversaturated sample, containing 70 % HCT, followed by annealing at a different temperature 95 for each cycle in order to reach the maximum solubility at each temperature. After the 96 annealing step the sample was quenched and heated again to determine the glass transition 97 temperature (Tg). These cycles were performed for different annealing temperatures in 98 between the melting point of polymer matrix and drug, and the shift in Tg was monitored using 99 a differential scanning calorimeter Q200, equipped with a refrigerated cooling system (RCS) 100 (TA Instruments, Leatherhead, UK). Nitrogen was used as purge gas through the DSC cell (50 101 ml/min) and the RCS unit (300 ml/min). Samples (± 3 mg) were run in an open aluminum pan 102
with an underlying heating rate of 5 °C/min. The modulation period and amplitude were set at 103 50 s and 0.663 °C, respectively (heat-only method). Temperature and enthalpy calibration was 104 performed with an indium standard at the same scan rate and with the same kind of pans used 105 in the experiment. MDSC data were analyzed using the TA instruments Universal Analysis 106 2000 V4.7A software. 107
X-ray diffraction 108
Crystallinity was analyzed using X-ray diffraction (XRD) on pure compounds, physical 109 mixtures and corresponding extrudates. X-ray diffraction was performed on a D5000 diffractor 110 with Cu Kα radiation (λ = 1.54 Å) (Siemens, Karlsruhe, Germany) and a voltage of 40 mV in 111 the angular range (2θ) varying from 10 to 60° using a step scan mode with a step size of 0.02° 112 and a measuring time of 1 s/step. 113
Terahertz pulsed imaging (TPI) 114
The calendered tablets from different formulations were analyzed using a TPI imaga2000 115 coating scan system (Teraview, Cambridge, UK). The operation of this system was previously 116 described by Zeitler et al. [15] . Images were acquired in a point-to-point mode with a step size 117 of 200 µm. Images were analyzed using TPI View (version 3.0.3, Teraview, Cambridge, UK). 118 reflectivity of the calendered tablets as well as by calibration using the X-ray micro-computed 121 tomography. Given the very smooth texture of the surface this was deemed to represent an 122 appropriate measurement for the refractive index as no surface scattering would contribute to 123 the losses. Using this value histograms and maps of coating uniformity were plotted using 124
Matlab (R2013a, The Mathworks, Natick MA, USA). 125 126 2.2.7 X-ray micro-computed tomography (Micro-CT) 127
The porosity of the mini-matrices and tablets was evaluated by means of micro-CT. Co-128 extruded mini-matrices and calendered tablets were scanned using a Skyscan 1172 high 129 resolution X-ray micro-CT system (Bruker microCT, Kontich, Belgium), operated at 59 kV 130 source voltage, with an image pixel size of 1.37 µm and 4.53 µm, for the mini-matrix and the 131 tablet, respectively. The scanning system is equipped with an aluminum 0.5 mm filter and an 132 11 Mp CCD detector. For the scan with the image pixel size of 4.53 µm the samples were 133 rotated over 0.4 ° steps, exposure time was 1000 ms and total scan duration was 42 min. For 134 the high resolution offset-scan the samples were rotated over 0.2 ° steps, exposure time was 135 2350 ms, frame averaging was 5 and total scan duration was 9 h 17 min. The images were 136 reconstructed with NRecon (Version 1.6.3.2, Bruker microCT, Kontich, Belgium) on a GPU-137 ReconServer. A Gaussian smoothing kernel of 2 pixels was applied, resulting in an 8-bit bitmap 138 (BMP) image with a linear X-ray attenuation coefficient, displayed as a grey scale value 139 calibrated between 0 and 255. To compare both dosage forms at the same pixel size, the 140 images of the mini-matrix system were resized fourfold prior to analysis. Data analysis and 141 visualization was done with CTAn software (version 1.13.5.1, Bruker microCT, Kontich, 142 Belgium) and CTVol (version 2.2, Bruker microCT, Kontich, Belgium) for surface rendering. 143
For image analysis the core was defined as the region of interest (ROI). To this end, applying 144 a Gaussian blur by 2 pixels allowed separating the two peaks in the grey scale histogram with 145 a threshold of 34. Pixels with lower intensities were assigned to the core and pixels with a 146 higher intensity were assigned to the coat layer. This ROI is applied to the original grey scale 147 images, in this way removing the coat. Greyscale images were binarised using an Otsu-148 algorithm, one of the most popular techniques of automatic thresholding [16] . 3D objects 149 smaller than 20 voxels were considered to be noise and were filtered out of the image used 150 for porosity analysis. A distinction is made between internal pores, which are located in the 151 core of the co-extrudate, and pores at the interface between core and coat. The percentage of 152 internal pores is quantified as the ratio between the internal pore volume in the core and the 153 object volume (i.e. total volume of solid core material, excluding pores). The percentage of 154 pores at the interface between both layers is defined as the ratio between the pore volume at 155 the interface and the total core volume (i.e. region of interest volume, including pores). A size 156 distribution of the pores is illustrates the percentage of pores in a certain range of structure 157 thickness. Local structure thickness for a point in solid material is defined by Hildebrand and 158
Ruegsegger as the diameter of the largest sphere that encloses the point and is entirely 159 enclosed within the solid surfaces [17] . 160 161
RESULTS AND DISCUSSION
In order to continuously shape a multi-layered co-extrudate into a final monolithic FDC 163 tablet dosage form the co-extrusion line was extended downstream with a calender and chiller. 164
Although calendering has been used previously to shape an extrudate into a final dosage form 165 [11, 12] , to our knowledge this study is the first to evaluate calendering as a downstream tool 166 in a co-extrusion process, thus producing a dosage form with an outer layer that is surrounding 167 the inner core. In order to evaluate the effect of calendering on the release profiles of two 168 model drugs, formulations with a MPT-loaded sustained release core and a HCT-loaded 169 immediate release coat were used (Table 1) cavities. The co-extruded string was guided between the chilled calender rolls to shape a string 179 of tablets. Calendered tablets were regular in shape and had a uniform aspect as long as the 180 calender rolls were chilled at 4 ± 1 °C. When the chiller did not succeed in adequately cooling 181 the calender rolls (i.e. using a chill water temperature > 6°C), the calendered tablets deformed 182 when the calendered string detached from the chill rolls. As aspect defects were found to be 183 highly dependent on calender speed and temperature, a low calender speed was used to allow 184 adequate cooling and perfect shaping of the calendered tablets [18] . The cooling rate of the 185 material between the calender rolls seemed essential to obtain a dosage form with good shape 186 and uniform dimensions (Fig. 1) . Although minimized by adjusting the die dimensions to the 187 dimensions of the calender cavities, waste material was created at the sides of the tabletsedges of the tablets must be removed to obtain the final dosage forms, this is especially a 191 disadvantage when working with highly valuable active ingredients. Based on the drug content 192 of the waste material, it was assessed that it is mainly composed of coat material (93 % of the 193 total waste fraction), while only a minor part of core material is lost during calendering. This 194 should be taken into account as this yields tablets with a higher MPT/HCT ratio than 195 theoretically anticipated based on coat and core composition. The higher MPT/HCT ratio was 196 confirmed by quantification of the MPT and HCT concentration in the calendered tablets: a 197 ratio of 8.58 vs. 8.00 based on the composition of coat and core layer. Since TPI was previously 198 used for the non-destructive analysis of coated tablets [19] this technique was used to visualize 199 the coat layer and to study the adhesion between core and coat. Especially interesting for the 200 analysis of calendered tablets via TPI is the fact that not only the thickness of the coat layer, 201 but also the uniformity and integrity of the coat can be analysed, since penetration depths into 202 typical pharmaceutical formulations between 1 and 3 mm can currently be achieved [14] . The 203 thickness of the coat layer varied between 200 and 600 µm (Fig. 2) . In the false-colour images 204 of the tablets of formulation B, a thickness gradient in the coat layer is observed (Fig. 2) , which 205 is more pronounced at the top face compared to the bottom face of the calendered tablets. 206
This gradient can be explained by the sequenced contact of different regions of the tablet with 207 the calender rolls. The cross section images based on the micro-CT data from a string of 208 tablets confirmed this by revealing a recurrent pattern of the thinner area in the coating layer 209 (Fig. 3) . The analysis of the calendered tablet via TPI also clearly identified that the adhesion 210 between core and coat was not complete as an air gap at the interface between both extruded 211 layers was detected (Fig. 2) . The incomplete adhesion was also confirmed by micro-CT (Fig.  212 3) and quantified as the percentage of pores at the intersection of core and coat. These pores 213 at the intersection of core and coat for calendered tablets (2.37 %) were also found for the 214 multiparticulates (2.06 %), indicating that the incomplete adhesion between coat and core wasinfluence on the release characteristics for a tablet with an immediate release coat (as 219 manufactured in this study) since the coat will rapidly dissolve and expose the core to the 220 dissolution medium. However, the results show that calendering as a post-processing step for 221 co-extruded formulations needs further optimization for drug delivery systems where the coat 222 controls the release of the core, as the differences in thickness of the coating layer and 223 incomplete adhesion between both layers observed in this study would induce significant 224 variability in the release rate. Moreover, for those types of systems it will be challenging to 225 obtain a coat that completely seals the core, a feat that is difficult to achieve with the 226 calendering set-up used in this study, especially at the edges of the calendered tablets (Fig.  227   3) . 
In equation 1 Tg(HCT) and Tg(carrier) are respectively the glass transition temperature of pure 237
HCT and the carrier, X(HCT) is the HCT fraction in the mixture, and K is a fitting parameter 238 characterizing the curvature of the evolution. of the core of the calendered tablet also revealed diffraction peaks of MPT, confirming that the 254 crystalline state of MPT was at least partially maintained in the tablets. Moreover, the X-ray 255 diffractogram did not reveal differences between the cores of calendered tablets and co-256 extruded mini-matrices (data not shown). The pore structure of the core in both dosage forms, 257 calendered tablets and mini-matrices, was compared using micro-CT. The percentage of 258 internal pores was 4.00 % and 1.08 % for the core of the mini-matrices and calendered tablets, 259 respectively. The lower amount of internal pores in the calendered tablet can be attributed to 260 the additional densification of the material during calendering. In addition, the internal pores in 261 the calendered tablet were smaller in size: an average structure thickness of 17 ± 20 µm, in 262 comparison to 83 ± 5 µm for the mini-matrix (Fig. 5) . However, these limited differences in 263 number and size of the internal pore structure are unlikely to have an impact on drug release. 264
The difference in sustained release of MPT between the monolithic calendered tablets and the 265 multiparticulates is illustrated in Figure 6 . The MPT burst release was reduced by half for all 266 calendered formulations in comparison with the mini-matrices. Moreover, the monolithic 267 calendered tablet sustained MPT release to a larger extent than the mini-matrices, with a 268 complete release after only 24 h instead of 8 h in case of formulation A. The lower mass 269 transport rates from the calendered tablets were linked to the dimensions of the dosage forms: 270 the core of the calendered tablet had a diameter of 7 mm and a thickness of 4 mm, whereasthe core of the mini-matrices had a diameter of 3 mm and a length of 2 mm. The importance 272 of relative surface area available highlighted the importance of diffusion path length for MPT 273 dissolution from the matrices and was confirmed by performing dissolution tests on cylindrical 274
extrudates with a similar surface area/volume ratio to the calendered tablet and on a central 275 part of the calendered tablet with the same dimensions as the mini-matrices. Both test set-ups 276 indicated that the diffusion path length is the main contributor for the differences in release 277 profiles observed between the calendered tablets and the multiparticulate formulation. Based 278 on the release data it is evident that manufacturing an easily swallowable tablet-shaped 279 monolithic dosage form offered an advantage over the multiparticulate formulation for 280 sustained drug release. For the calendered formulation B, with 5 % PEO and 30 % drug 281 content, MPT release after 48 h was only 75 %. In contrast, complete drug release from 282 formulation C (containing 20 % PEO and 15 % MPT) was obtained after 48 h (Fig. 6 ). These 283 differences in release profiles indicated that PEO was the main contributor for drug release. 284
Because of the smaller dimensions of the mini-matrices, the matrix effect was of lesser 285 importance for MPT release from the multiparticulates. The type of dosage form did not 286 influence the immediate release profile of HCT, with a complete release within 45 min for all 287 formulations (Fig. 7) . To assess the impact of cooling during calendering (essential to avoid 288 sticking of the dosage form to the rolls), the effect of the cooling rate on MPT release from the 289 calendered tablets was determined. Cooling was performed via quench-cooling in liquid 290 nitrogen or via cooling at room temperature. However, the MPT release profiles were 291 independent of the cooling technique. Moreover, X-ray diffractograms of the extrudates of 292 formulations A and B demonstrated that cooling rate did not affect crystallinity of MPT in these 293 formulations (Fig. 8) . 
CONCLUSION 295
In this study we have demonstrated that calendering is a promising downstream processing 296 step to continuously produce tablet-shaped monolithic FDC dosage forms from multi-layered 297 matrix co-extrudates. With the calendered tablet an in vitro MPT release was sustained over 298 24 to 48 h, in combination with an immediate HCT release from the coat. The differences in 299 diffusion path length of the final monolithic tablet-shaped dosage form mainly determined the 300 MPT release from the core. Calendering and cooling did not affect the sustained MPT release 301 profiles. A limited reduction of the porosity of the core after calendering indicated some 302 additional densification of the material during calendering. The shaping technique did not alter 303 the solid state of the drugs. Further characterization using TPI revealed a gradient in coat 304 thickness and incomplete adhesion between core and coat, the latter being inherent to the co-305 extrudate and independent of the calendering step, as visualized by micro-CT. This implied 306 that at the present stage of development calendering is promising to shape FDC dosage forms 307 with an immediate release coat, but when a sustained or extended release coat needs to be 308 applied the technique is not an adequate solution. 309 
